Your browser doesn't support javascript.
loading
Hepatic Steatosis as a Predictive Factor of Antiviral Effect of Pegylated Interferon Therapy in Patients With Hepatitis B.
Gong, L; Liu, J; Wang, J; Lou, G Q; Shi, J P.
Afiliação
  • Gong L; Department of Liver Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China.
  • Liu J; Department of Liver Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China.
  • Wang J; Department of Liver Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China.
  • Lou GQ; Department of Liver Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China.
  • Shi JP; Department of Liver Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China. Electronic address: qunpingshihz@sina.com.
Transplant Proc ; 47(10): 2886-91, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26707308
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Interferon-alfa / Hepatite B Crônica / Fígado Gorduroso Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Interferon-alfa / Hepatite B Crônica / Fígado Gorduroso Idioma: En Ano de publicação: 2015 Tipo de documento: Article